Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.

Lipid monitoring in patients with schizophrenia prescribed second-generation antipsychotics.

Weissman EM, Zhu CW, Schooler NR, Goetz RR, Essock SM.

J Clin Psychiatry. 2006 Sep;67(9):1323-6.

PMID:
17017817
2.

Monitoring metabolic side effects when initiating treatment with second-generation antipsychotic medication.

Weissman E, Jackson C, Schooler N, Goetz R, Essock S.

Clin Schizophr Relat Psychoses. 2012 Jan;5(4):201-7. doi: 10.3371/CSRP.5.4.4.

PMID:
22182457
3.

Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients.

Morrato EH, Cuffel B, Newcomer JW, Lombardo I, Kamat S, Barron J.

J Clin Psychopharmacol. 2009 Feb;29(1):26-32. doi: 10.1097/JCP.0b013e31819294cb.

PMID:
19142103
4.

Predictors of metabolic monitoring among schizophrenia patients with a new episode of second-generation antipsychotic use in the Veterans Health Administration.

Shi L, Ascher-Svanum H, Chiang YJ, Zhao Y, Fonseca V, Winstead D.

BMC Psychiatry. 2009 Dec 18;9:80. doi: 10.1186/1471-244X-9-80.

5.

Metabolic monitoring in veterans with schizophrenia-related disorders and treated with second-generation antipsychotics: findings from a Veterans Affairs-based population.

Hsu C, Ried LD, Bengtson MA, Garman PM, McConkey JR, Rahnavard F.

J Am Pharm Assoc (2003). 2008 May-Jun;48(3):393-400. doi: 10.1331/JAPhA.2008.07007.

PMID:
18595825
6.

LDL cholesterol estimation using the Anandaraja's and Friedewald's formulas in schizophrenic patients treated with antipsychotic drugs.

Paz E, Hermida J, Bouzas L, Brenlla J, Tutor JC.

Clin Biochem. 2008 Aug;41(12):1002-7. doi: 10.1016/j.clinbiochem.2008.04.017. Epub 2008 Apr 27.

PMID:
18474233
7.

Hyperlipidemia in persons using antipsychotic medication: a general population-based birth cohort study.

Saari K, Koponen H, Laitinen J, Jokelainen J, Lauren L, Isohanni M, Lindeman S.

J Clin Psychiatry. 2004 Apr;65(4):547-50.

PMID:
15119919
8.

Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.

Coodley GO, Jorgensen M, Kirschenbaum J, Sparks C, Zeigler L, Albertson BD.

Am J Med. 2008 Jul;121(7):604-10. doi: 10.1016/j.amjmed.2008.02.031. Epub 2008 Jun 4.

PMID:
18538295
9.

Risk of cardiovascular events in patients at optimal values for combined lipid parameters.

Stanek EJ, Sarawate C, Willey VJ, Charland SL, Cziraky MJ.

Curr Med Res Opin. 2007 Mar;23(3):553-63.

PMID:
17357251
10.

Metabolic syndrome in female patients with schizophrenia treated with second generation antipsychotics: a 3-month follow-up.

Medved V, Kuzman MR, Jovanovic N, Grubisin J, Kuzman T.

J Psychopharmacol. 2009 Nov;23(8):915-22. doi: 10.1177/0269881108093927. Epub 2008 Jul 17.

PMID:
18635691
11.
12.

Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting.

Mosca L, Merz NB, Blumenthal RS, Cziraky MJ, Fabunmi RP, Sarawate C, Watson KE, Willey VJ, Stanek EJ.

Circulation. 2005 Feb 1;111(4):488-93.

13.

An evaluation of monitoring practices in patients on second generation antipsychotics.

Nguyen D, Brakoulias V, Boyce P.

Australas Psychiatry. 2009 Aug;17(4):295-9. doi: 10.1080/10398560902842519.

PMID:
19585292
14.

Increased dyslipidemia in schizophrenic outpatients using new generation antipsychotics.

Leitão-Azevedo CL, Guimarães LR, de Abreu MG, Gama CS, Lobato MI, Belmonte-de-Abreu PS.

Rev Bras Psiquiatr. 2006 Dec;28(4):301-4.

15.

Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics.

Correll CU, Frederickson AM, Kane JM, Manu P.

Bipolar Disord. 2008 Nov;10(7):788-97. doi: 10.1111/j.1399-5618.2008.00625.x.

PMID:
19032710
16.

Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorder.

De Hert M, Kalnicka D, van Winkel R, Wampers M, Hanssens L, Van Eyck D, Scheen A, Peuskens J.

J Clin Psychiatry. 2006 Dec;67(12):1889-96.

PMID:
17194266
17.
18.

Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.

Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T.

Clin Ther. 2007 Aug;29(8):1671-81.

PMID:
17919548
19.

Serum lipid profiles including non-high density lipoprotein cholesterol levels in Turkish school-children.

Uçar B, Kiliç Z, Dinleyici EC, Colak O, Güneş E.

Anadolu Kardiyol Derg. 2007 Dec;7(4):415-20.

20.

[Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].

Bret P, Bret MC, Queuille E.

Encephale. 2009 Apr;35(2):129-38. doi: 10.1016/j.encep.2008.03.007. Epub 2008 Jul 7. French.

PMID:
19393381

Supplemental Content

Support Center